Thunder Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs
News provided by
Share this article
Share this article
GUANGZHOU, China, Feb. 22, 2021 /PRNewswire/ AnchorDx Medical Co., Ltd. ( AnchorDx ) announced the completion of a USD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment, an investment fund focusing on the health and wellness industry. To date, AnchorDx has successfully attracted well-known investors including the top biopharmaceutical and medical diagnosis companies Wuxi AppTec and KingMed Diagnostics, as well as leading investment funds such as Northern Light Venture Capital, 6 Dimensions Capital, Serica Jianxin Venture Capital, Arch Venture Partners, Marathon Venture Partners, OrbiMed, and WuXi Huiying Investment. ....

Zhong Nanshan , United States , David Wang , Chinese Academy Of Engineering , American Association For Cancer Research , Prnewswire Anchordx Medical Co Ltd , Wuxi Huiying Investment , Wuxi Apptec , Kingmed Diagnostics , Northern Light Venture Capital , Serica Jianxin Venture Capital , Arch Venture Partners , Marathon Venture Partners , Wuxi Huiying , Fan Jian Bing , American Association , Cancer Research , Chinese Academy , Thunder Project , Pulmoseek Plus , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் வாங் , சீன கலைக்கழகம் ஆஃப் பொறியியல் , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , வடக்கு ஒளி துணிகர மூலதனம் , வளைவு துணிகர கூட்டாளர்கள் ,